Patent · US Active

HCV polymerase inhibitors

US9540411B2 · kind B2 · utility

39Cited by

3References

17Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Genadiy Kalayanov · Huddinge, SE
Staffan Torssell · Bromma, SE
Horst Wahling · Huddinge, SE

Key dates

Filing date	Jul 14, 2016
Grant date	Jan 10, 2017
Priority date	—
Expiry date	Jul 14, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H23/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of the formula:wherein B is a nucleobase selected from the groups (a) to (d):and the other variables are as defined in the claims,which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.